🤡🌍📢

Fiat news at its finest: Front page of The Times this morning - https://www.thetimes.co.uk/article/sleeping-pill-reduce-risk-alzheimers-disease-study-2023-5mnt63lxq

Literally a single study showing something that **is not** actually a reduction in Alzheimers, but rather a reduction in a protein with a tenuous association with the disease.

There were plenty of stronger results for Ivermectin and Covid which were outright ignored (the fact that Ivermectin turned out not to be not that effective is irrelevant to this point).

So the question is: why is a drug sold by Merck at $500 per month with no evidence of efficacy being pushed as front page news?

Reply to this note

Please Login to reply.

Discussion

No replies yet.